| 02 Jun, 06:55 pm | — | … | Alembic Pharmaceuticals Ltd - 533573 - Announcement under Regulation 30 (LODR)-Change in Management | bse |
| 02 Jun, 06:54 pm | — | … | Alembic Pharmaceuticals Limited has informed the Exchange about change in Management | nse |
| 01 Jun, 06:57 pm | — | … | Alembic Pharmaceuticals Ltd - 533573 - Announcement under Regulation 30 (LODR)-Change in Management | bse |
| 01 Jun, 06:56 pm | — | … | Alembic Pharmaceuticals Limited has informed the Exchange about change in Management | nse |
| 22 May, 10:59 am | — | … | Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated May 22, 2026, titled "Alembic Pharmaceuticals Limited receives USFDA Final Approval for Levothyroxine Sodium Tablets USP". | nse |
| 22 May, 10:59 am | — | … | Alembic Pharmaceuticals Ltd - 533573 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 21 May, 03:30 pm | — | … | Alembic Pharmaceuticals Limited has informed the Exchange about Transcript | nse |
| 21 May, 03:30 pm | — | … | Alembic Pharmaceuticals Ltd - 533573 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript | bse |
| 18 May, 03:52 pm | — | … | Chirayu Amin has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. | nse |
| 16 May, 01:49 pm | — | … | Alembic Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publication of Audited Financial Results as on 31st March, 2026. | nse |
| 15 May, 09:00 pm | — | … | Alembic Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026. | nse |
| 15 May, 08:28 pm | — | … | Alembic Pharmaceuticals Limited has informed the Exchange regarding 'Alembic Pharmaceuticals Limited passes ANVISA (Brazil) GMP Inspection for its API-III Facility at Karakhadi'. | nse |
| 15 May, 06:37 pm | — | … | Alembic Pharmaceuticals Limited has informed the Exchange about Link of Recording | nse |
| 15 May, 06:35 pm | — | … | Alembic Pharmaceuticals Ltd - 533573 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome | bse |
| 15 May, 02:57 pm | — | … | Alembic Pharmaceuticals Limited has informed the Exchange that Board of Directors at its meeting held on May 15, 2026, recommended Final Dividend of Rs. 12 per equity share. | nse |
| 15 May, 02:55 pm | — | … | Alembic Pharmaceuticals Ltd - 533573 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 15 May, 02:54 pm | — | … | Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated May 15, 2026, titled "Press Release for the Quarter ended 31st March, 2026". | nse |
| 15 May, 02:53 pm | — | … | Alembic Pharmaceuticals Ltd - 533573 - Announcement under Regulation 30 (LODR)-Investor Presentation | bse |
| 15 May, 02:51 pm | — | … | Alembic Pharmaceuticals Ltd - 533573 - Audited Financial Results For The Quarter And Financial Year Ended 31St March, 2026 | bse |
| 15 May, 02:51 pm | — | … | Alembic Pharmaceuticals Limited has informed the Exchange about Investor Presentation | nse |
| 15 May, 02:50 pm | — | … | Alembic Pharmaceuticals Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026. | nse |
| 15 May, 02:48 pm | — | … | Outcome of Board meeting | nse |
| 14 May, 07:04 pm | — | … | Alembic Pharmaceuticals Limited has informed the Exchange about Resignation of Director/KMP/SMP | nse |
| 14 May, 07:01 pm | — | … | Alembic Pharmaceuticals Limited has informed the Exchange about change in Management: Resignation of Senior Management Personnel. | nse |
| 14 May, 06:58 pm | — | … | Alembic Pharmaceuticals Ltd - 533573 - Announcement under Regulation 30 (LODR)-Change in Management | bse |
| 14 May, 11:10 am | — | … | Alembic Pharmaceuticals Limited has informed the Exchange regarding 'Alembic Pharmaceuticals Limited receives Establishment Inspection Report (EIR) for its Injectable Facility (F-III) located at Karakhadi.'. | nse |
| 14 May, 10:09 am | — | … | Alembic Pharmaceuticals Ltd - 533573 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 14 May, 10:08 am | — | … | Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated May 14, 2026, titled "Alembic Pharmaceuticals Limited receives USFDA Tentative Approval for Darolutamide Tablets, 300 mg.". | nse |
| 09 May, 02:30 pm | — | … | Alembic Pharmaceuticals Ltd - 533573 - Compliances-Reg.24(A)-Annual Secretarial Compliance | bse |
| 04 May, 08:17 pm | — | … | Alembic Pharmaceuticals Limited has informed the Exchange about General Updates | nse |
| 04 May, 08:16 pm | — | … | Alembic Pharmaceuticals Ltd - 533573 - Intimation Under Reg 30 Of SEBI (LODR), Regulations, 2015 | bse |
| 04 May, 07:47 pm | — | … | Alembic Pharmaceuticals Limited has informed the Exchange about Resignation of Director/KMP/SMP | nse |
| 04 May, 07:35 pm | — | … | Alembic Pharmaceuticals Limited has informed the Exchange about Resignation of Director/KMP/SMP | nse |
| 04 May, 07:31 pm | — | … | Alembic Pharmaceuticals Limited has informed the Exchange about Resignation of Senior Management Personnel | nse |
| 04 May, 07:28 pm | — | … | Alembic Pharmaceuticals Ltd - 533573 - Announcement under Regulation 30 (LODR)-Change in Management | bse |
| 01 May, 10:41 am | — | … | Alembic Pharmaceuticals Limited has informed the Exchange about change in Management-Designated as Senior Management Personnel | nse |
| 01 May, 10:40 am | — | … | Alembic Pharmaceuticals Ltd - 533573 - Announcement under Regulation 30 (LODR)-Change in Management | bse |
| 27 Apr, 01:20 pm | — | … | Alembic Pharmaceuticals Ltd - 533573 - Board Meeting Intimation for Considering Audited Financial Results For The Quarter And
Financial Year Ended 31St March, 2026 | bse |
| 27 Apr, 12:23 pm | — | … | Alembic Pharmaceuticals Limited has informed the Exchange regarding Demise of Mr. Saibal Mukherjee, Resident Director (Delhi Office) of the company on April 26, 2026. | nse |
| 27 Apr, 12:08 pm | — | … | Alembic Pharmaceuticals Ltd - 533573 - Announcement under Regulation 30 (LODR)-Demise | bse |
| 25 Apr, 11:58 am | — | … | Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated April 25, 2026, titled "Alembic Pharmaceuticals Limited receives USFDA Final Approval for Fingolimod Capsules 0.5 mg.". | nse |
| 25 Apr, 11:55 am | — | … | Alembic Pharmaceuticals Ltd - 533573 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 23 Apr, 01:17 pm | — | … | Alembic Pharmaceuticals Limited has informed the Exchange about General Updates - Incorporation Of Wholly-Owned Subsidiary Company | nse |
| 23 Apr, 01:15 pm | — | … | Alembic Pharmaceuticals Ltd - 533573 - Intimation Under Regulation 30 Of SEBI LODR Regulations, 2015 - Incorporation Of Wholly-Owned Subsidiary Company | bse |
| 22 Apr, 07:05 pm | — | … | Alembic Pharmaceuticals Ltd - 533573 - Intimation Under Regulation 30 Of SEBI LODR Regulations, 2015 - Incorporation Of Subsidiary Company | bse |
| 22 Apr, 07:04 pm | — | … | Alembic Pharmaceuticals Limited has informed the Exchange about General Updates - Incorporation of Subsidiary Company. | nse |
| 16 Apr, 11:17 am | — | … | Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated April 16, 2026, titled "Alembic Pharmaceuticals Limited receives USFDA Final Approval for Methotrexate Injection USP". | nse |
| 16 Apr, 11:14 am | — | … | Alembic Pharmaceuticals Ltd - 533573 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 07 Apr, 12:25 pm | — | … | Alembic Pharmaceuticals Ltd - 533573 - Announcement under Regulation 30 (LODR)-Press Release / Media Release | bse |
| 07 Apr, 12:24 pm | — | … | Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated April 07, 2026, titled "Alembic Pharmaceuticals Limited receives USFDA Final Approval for Dapagliflozin Tablets, 5 mg and 10 mg.". | nse |